Search research articles
Contact Us
Filters
Showing results (41-50 of 98) with videos related to
Page
of 10
Sort By:
Lupus
|
February 9, 2017
Trigger factors of cutaneous lupus erythematosus: a review of current literature
J Szczęch, D Samotij, V P Werth, et al.
Archives of Dermatological Research
|
October 1, 2008
TNF-alpha production in the skin
M M Bashir, M R Sharma, V P Werth
Lupus
|
October 1, 2016
Biological therapies in the treatment of cutaneous lupus erythematosus
J K Presto, E Z Hejazi, V P Werth
The British Journal of Dermatology
|
November 8, 2020
Patient-oriented outcomes for atopic dermatitis
T Vazquez, J S S Concha, V P Werth
The British Journal of Dermatology
|
December 28, 2021
Postinflammatory hyperpigmentation and erythema: new insights into the pathogenesis
J S S Concha, M Afarideh, V P Werth
Current Opinion in Rheumatology
|
October 6, 1997
Pathogenetic mechanisms and treatment of cutaneous lupus erythematosus
V P Werth, J P Dutz, R D Sontheimer
Archives of Dermatological Research
|
September 28, 1998
Lack of correlation of skin thickness with bone density in patients receiving chronic glucocorticoid
V P Werth, A M Kligman, X Shi, et al.
The British Journal of Dermatology
|
March 29, 2019
Evaluating cutaneous lupus disease activity end points and their effects on quality of life as an outcome measure for clinical trials
M Tarazi, R G Gaffney, R Feng, et al.
Journal of the American Academy of Dermatology
|
December 1, 1993
Linear hyperpigmentation overlying veins in association with collagen vascular disease
V P Werth, H R Schumacher, J M Von Feldt
The British Journal of Dermatology
|
June 10, 2014
Improvement in the cutaneous disease activity of patients with dermatomyositis is associated with a better quality of life
E S Robinson, R Feng, J Okawa, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 98) with videos related to
Sort By:
Page
of 10
Lupus
|
February 9, 2017
Trigger factors of cutaneous lupus erythematosus: a review of current literature
J Szczęch, D Samotij, V P Werth, et al.
Archives of Dermatological Research
|
October 1, 2008
TNF-alpha production in the skin
M M Bashir, M R Sharma, V P Werth
Lupus
|
October 1, 2016
Biological therapies in the treatment of cutaneous lupus erythematosus
J K Presto, E Z Hejazi, V P Werth
The British Journal of Dermatology
|
November 8, 2020
Patient-oriented outcomes for atopic dermatitis
T Vazquez, J S S Concha, V P Werth
The British Journal of Dermatology
|
December 28, 2021
Postinflammatory hyperpigmentation and erythema: new insights into the pathogenesis
J S S Concha, M Afarideh, V P Werth
Current Opinion in Rheumatology
|
October 6, 1997
Pathogenetic mechanisms and treatment of cutaneous lupus erythematosus
V P Werth, J P Dutz, R D Sontheimer
Archives of Dermatological Research
|
September 28, 1998
Lack of correlation of skin thickness with bone density in patients receiving chronic glucocorticoid
V P Werth, A M Kligman, X Shi, et al.
The British Journal of Dermatology
|
March 29, 2019
Evaluating cutaneous lupus disease activity end points and their effects on quality of life as an outcome measure for clinical trials
M Tarazi, R G Gaffney, R Feng, et al.
Journal of the American Academy of Dermatology
|
December 1, 1993
Linear hyperpigmentation overlying veins in association with collagen vascular disease
V P Werth, H R Schumacher, J M Von Feldt
The British Journal of Dermatology
|
June 10, 2014
Improvement in the cutaneous disease activity of patients with dermatomyositis is associated with a better quality of life
E S Robinson, R Feng, J Okawa, et al.
Page
of 10